Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 14:11:2042018820958329.
doi: 10.1177/2042018820958329. eCollection 2020.

Autoimmune thyroid disease and type 1 diabetes mellitus: same pathogenesis; new perspective?

Liyan Li  1 , Shudong Liu  2 , Junxia Yu  3
Affiliations
Review

Autoimmune thyroid disease and type 1 diabetes mellitus: same pathogenesis; new perspective?

Liyan Li et al. Ther Adv Endocrinol Metab. .

Abstract

Autoimmune thyroid disease (AITD) and type 1 diabetes mellitus (T1DM) are two common autoimmune diseases that can occur concomitantly. In general, patients with diabetes have a high risk of AITD. It has been proposed that a complex genetic basis together with multiple nongenetic factors make a variable contribution to the pathogenesis of T1DM and AITD. In this paper, we summarize current knowledge in the field regarding potential pathogenic factors of T1DM and AITD, including human leukocyte antigen, autoimmune regulator, lymphoid protein tyrosine phosphatase, forkhead box protein P3, cytotoxic T lymphocyte-associated antigen, infection, vitamin D deficiency, and chemokine (C-X-C motif) ligand. These findings offer an insight into future immunotherapy for autoimmune diseases.

Keywords: autoimmune thyroid disease; autoimmunity; genetics; type 1 diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: The author(s) declare that there is no conflict of interest.

Figures

Figure 1.
Figure 1.
A flow diagram of the literature retrieval process.
Figure 2.
Figure 2.
Proposed diagram of the pathogenic mechanisms involved in the development and progression of thyroid autoimmune disease and type 1 diabetes mellitus. AIRE, autoimmune regulator; AITD, autoimmune thyroid disease; CTLA-4, cytotoxic T lymphocyte-associated antigen-4; CXCLs, chemokine (C-X-C motif) ligands; FOXP3, forkhead box protein P3; HLA, human leukocyte antigen; PTP/LYP, lymphoid protein tyrosine phosphatase; Th, T helper cell; T1DM; type 1 diabetes mellitus; Treg, regulatory T cells; TSHR, thyroid-stimulating hormone receptor; VD, vitamin D; VDR, vitamin D receptor.
See this image and copyright information in PMC

References

    1. Ruggeri RM, Giuffrida G, Campenni A. Autoimmune endocrine diseases. Minerva Endocrinol 2018; 43: 305–322. - PubMed
    1. Hadj-Kacem H, Rebuffat S, Mnif-Feki M, et al. Autoimmune thyroid diseases: genetic susceptibility of thyroid-specific genes and thyroid autoantigens contributions. Int J Immunogenet 2009; 36: 85–96. - PubMed
    1. Tomer Y, Huber A. The etiology of autoimmune thyroid disease: a story of genes and environment. J Autoimmun 2009; 32: 231–239. - PMC - PubMed
    1. Weetman AP, McGregor AM. Autoimmune thyroid disease: further developments in our understanding. Endocr Rev 1994; 15: 788–830. - PubMed
    1. Moriguchi M, Noso S, Kawabata Y, et al. Clinical and genetic characteristics of patients with autoimmune thyroid disease with anti-islet autoimmunity. Metabolism 2011; 60: 761–766. - PubMed

LinkOut - more resources